AcelRx Pharmaceuticals Inc

Healthcare
$0.67
-0.07(9.73%) 1D
1D
1W
1M
1Y
3Y
5Y

Performance

Open PricePrev. CloseVolumeAvg. Volume
$0.75$0.74348,185424,500

Fundamentals

Market Cap$11.00M
P/B Ratio1.1
P/E Ratio-0.3
Enterprise Value$3.60M
Div. Yield0.00%
Book Value0.95
EPS(TTM)-0.40
ROENA
Understand Fundamentals

About the Company

AcelRx Pharmaceuticals, Inc. is a specialty pharmaceuticals corporation that is focused on the development and commercialization of new therapies for treatment and cure for acute pain. Its flagship product candidate, DSUVIATM (known as ARX-04 outside of the United States), and its product candidate, ZALVISO, both use sublingual sufentanil, which is administered via a non-invasive method. The organization plans to build a supply capacity and commercial organization to market and sell DSUVIA in the United States on its own, as well as possible with strategic partners in select European Economic Area, or EEA, nations. In markets where the firm decides not to commercialize, the company may attempt to out-license commercialization rights. The firm intends to pursue regulatory clearance for ZALVISO in the United States and, if successful, to possibly promote ZALVISO either independently or in collaboration with strategic partners.;
OrganisationAcelRx Pharmaceuticals Inc

Company Financials

*All values are in Million $
No Graph Data To Display
Quarterly
Yearly

Similar Stocks

COMPANYMARKET PRICECLOSE PRICEMARKET CAP
Want to invest in US Stocks?
Signup with Groww to get started
Login / Register
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.3.0
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ